Pharma digs in on changes it wants from Trump administration
By Deena Beasley SAN FRANCISCO (Reuters) – The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for
By Deena Beasley SAN FRANCISCO (Reuters) – The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for
(Reuters) – UnitedHealth Group (NYSE:UNH) reported fourth-quarter revenue below Wall Street estimates on Thursday, hurt by weakness in its health insurance unit,
(Reuters) – Swiss plumbing products maker Geberit (SIX:GEBN) expects the construction market in the United States to be stable this
By Summer Zhen HONG KONG (Reuters) – Asian hedge funds delivered their strongest returns in 15 years last year, capitalising on market volatility,
Investing.com — All five major banks—JPMorgan Chase & Co (NYSE:JPM), Wells Fargo (NYSE:WFC), Goldman Sachs Group (NYSE:GS),
Investing.com — Whitbread (LON:WTB) on Thursday reported a modest sales in the UK for the third quarter of fiscal year
Investing.com — The rapid rise in interest rates over recent weeks has fueled volatility in US equities, but UBS strategists believe that
By Shashwat Chauhan (Reuters) – European shares advanced on Thursday, as heavyweight luxury stocks got a boost following Richemont (SIX:CFR)’s upbeat
Investing.com — Shares of Taylor Wimpey (LON:TW) fell over 3% on Thursday after it flagged concerns over rising costs, particularly in
BEIJING (Reuters) – Preliminary findings showed that PVH Corp (NYSE:PVH), the parent company of Calvin Klein and Tommy Hilfiger, engaged in “improper”